What "Reliable" Actually Means in a Third-Party Manufacturing Company

Every manufacturer is reliable in month one. Everyone ships the first order, everyone answers the phone, everyone is delighted to have you. Reliability is not a thing you can observe at the start of a relationship — which is why almost nobody checks for it, and why it is the thing that ends most of these arrangements.

Here is what reliability actually consists of, and how to test for it before you find out the hard way.

The month-nine problem

Month one, everyone ships. Month nine, your best doctor is writing forty strips a week of one brand and the plant runs short of an API. Now somebody, somewhere, decides which customer gets the batch.

If your company sends that plant a purchase order and nothing else, it finds out about the shortage afterwards. Then you find out. Then your doctor finds out — from the chemist, when the stock is not there. He switches, and he does not switch back. You did not lose an order. You lost a prescription you spent nine months building.

That is what unreliability actually costs, and it never shows up in the rate.

What reliability is made of

Stock and dispatch discipline

A dispatch commitment in writing, not a verbal "four weeks." And the harder question: what happens to that timeline when your order triples? A manufacturer who cannot answer has thought about this order, not about your business.

Who else that plant serves

The single best predictor, and almost nobody asks it. A plant making stock for one marketing company is inspected by the drug controller and nobody else. A plant manufacturing on contract for other pharmaceutical companies is audited by every one of them — on their schedule, to their standard, with their brand on the strip and the power to cancel.

That discipline cannot be negotiated into your agreement. It is either already there or it is not. You will never audit a plant yourself; you only need to know who already does.

Documentation without being chased

Batch manufacturing record and certificate of analysis with every consignment, as standard. A manufacturer you have to chase for a COA in month two will be a manufacturer you cannot reach in month nine.

Owning the licence

If the company you signed with does not own the plant, your urgency has to travel through an intermediary before it reaches anyone who can act. Ask whose drug licence your product is manufactured under. The answer is printed on your pack either way.

Honesty about scope

A manufacturer that takes an order for a dosage form its site certificate does not cover is not reliable — it is desperate. Beta-lactams need physically segregated premises by law; ophthalmics and injectables need sterile lines. A plant that says "we can't do that, here's why" in the first meeting is showing you exactly how it will behave in a shortage.

How to test for it before you sign

1. Ask for the site certificate before the rate. Speed and willingness of that reply is your first real data point.
2. Ask whose licence your product is made under. Vagueness here predicts vagueness later.
3. Ask who else the plant manufactures for.
4. Ask what happens to lead time if the order triples.
5. Ask what happens when an API is short. The quality of that answer tells you everything. "It doesn't happen" is not an answer.

The full list of red flags is here, and the seven checks are here.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

Who else audits it: the plant manufactures on contract for other Indian pharmaceutical companies. Their brand goes on the strip and their reputation sits in that plant's hands, so their auditors go through batch records with the power to cancel a contract. That happens whether the plant enjoys it or not.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products. We would rather lose the order than take one we cannot serve.

Not manufacturing at all? A PCD pharma franchise puts stock reliability on the company rather than on you — a monopoly territory and a ready range from ₹25,000. Here is the difference.

Frequently asked questions

What makes a third-party manufacturing company reliable?

Dispatch commitments in writing, documentation supplied without chasing, ownership of the licence your product is made under, honesty about which dosage forms it can legally produce, and other pharmaceutical companies auditing the same plant. Every manufacturer performs in month one; these are what predict month nine.

What happens if a pharma manufacturer runs short of raw material?

Someone decides which customer gets the batch. Ask this question before signing and judge the answer — "it doesn't happen" is not an answer. A plant supplying other pharmaceutical companies cannot quietly deprioritise, because those customers audit it and can cancel.

How do I check a manufacturer's supply reliability before signing?

Ask for the site certificate before the rate and note how fast it arrives. Ask whose licence your product is made under, who else the plant serves, what happens to lead time if your order triples, and what happens when an API is short. The willingness to answer is the test.

Why does a stock-out cost more than the lost order?

Because you lose the prescription, not the sale. A doctor whose patient cannot find your brand at the chemist writes something else, and prescriptions built over months do not return quickly. That cost never appears in the per-unit rate you compared.